Evidence map›Paper›PMID 25704570›Full record

ArticleAlcoholism, clinical and experimental research2015

Novel serum biomarkers for detection of excessive alcohol use.

Suthat Liangpunsakul, Xianyin Lai, Ruth A Ross, Zhangsheng Yu, Elizabeth Modlik, Chi Westerhold, Laura Heathers, Robin Paul, Sean O'Connor, David W Crabb and 1 more

Abstract read
In one paragraph

Article in Alcoholism, clinical and experimental research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. RNA biomarkers for alcohol use disorder.Frontiers in molecular neuroscience · 2022
    Review
  7. Epigenetic Biomarkers for Environmental Exposures and Personalized Breast Cancer Prevention.International journal of environmental research and public health · 2020
    Article
  8. Article
  9. Article
  10. Development and validation of a composite score for excessive alcohol use screening.Journal of investigative medicine : the official publication of the American Federation for Clinical Research · 2016
    Article
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Suthat LiangpunsakulDivision of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana; Roudebush Veterans Administration Medical Center, Indianapolis, Indiana.
Xianyin Lai
Ruth A Ross
Zhangsheng Yu
Elizabeth Modlik
Chi Westerhold
Laura Heathers
Robin Paul
Sean O'Connor
David W Crabb
Frank Witzmann

Funding

Translational Research and Science Education (OUT)P60AA007611 · NIAAA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI Marian Lee Logrip · 2003 to 2026
$45.5M
Quality Assurance and Quality Control Project Management: Improving Submissions and Study Conduct in the Human Subjects Research Prior Approval ProcessUL1TR002529 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI MOE, SHARON M, WIEHE, SARAH ELIZABETH · 2018 to 2022
$27.2M
Indiana Clinical and Translational Sciences InstituteUL1TR001108 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI DENNE, SCOTT C., SHEKHAR, ANANTHA · 2013 to 2017
$23.3M
Genetic risk factors for alcoholic cirrhosis - genome-wide case-control studyU01AA018389 · NIAAA · SOUTHERN CALIFORNIA INST FOR RES/EDUC · PI CORDELL, HEATHER JANE, DALY, ANN · 2011 to 2018
$3.0M
Effect of ethanol on Kupffer cell/hepatocyte interactions and lipid metabolismK08AA016570 · NIAAA · INDIANA UNIVERSITY INDIANAPOLIS · PI LIANGPUNSAKUL, SUTHAT · 2008 to 2012
$659k
Genetic risk factors for alcoholic cirrhosis - genome-wide case-control studyR01AA018389 · NIAAA · SOUTHERN CALIFORNIA INST FOR RES/EDUC · PI CORDELL, HEATHER JANE, DALY, ANN · 2019 to 2019
$336k
Serum Proteomic Profiles as Biomarkers of Abusive Alcohol ConsumptionI01CX000361 · VA · RLR VA MEDICAL CENTER · PI LIANGPUNSAKUL, SUTHAT · 2012 to 2025
–
CSRD VA I01 CX000361NCATS NIH HHS UL1 TR001108NIAAA NIH HHS K08 AA016570NIAAA NIH HHS P60 AA007611NIAAA NIH HHS R01 AA018389NIAAA NIH HHS U01 AA018389
6 · The paper itself

Abstract

backgroundConstruct interview that correctly identifies those with alcohol use disorder have limitation, especially when the subjects are motivated to minimize the magnitude of drinking behavior. Current laboratory tests to detect excessive alcohol consumption are limited by marginal sensitivity/specificity. Excessive drinking has been shown to affect several organ systems, which may be reflected in changes in quantity of plasma proteins. Our aim was to employ novel proteomic analyses to identify potential markers for excessive alcohol use.

methodsA prospective case-control study included 49 controls and 54 excessive drinkers (discovery cohort). The serum proteomic analyses in these subjects were performed, and the results were tested in the verification cohort (40 controls and 40 excessive drinkers).

resultsUsing the appropriate cutoff and confirmation with ELISA, we identified 4 proteins which were significantly elevated in the serum of excessive drinkers: AT-rich interactive domain-containing protein 4B (ARID4B), phosphatidylcholine-sterol acyltransferase (LCAT), hepatocyte growth factor-like protein (MST1), and ADP-ribosylation factor 6 (ARL6). The performance of the conventional markers (aspartate aminotransferase [AST], alanine aminotransferase [ALT], gamma-glutamyl transpeptidase [GGT], percentage of carbohydrate-deficient transferrin [%CDT], and mean corpuscular volume [MCV]) discriminating between excessive alcohol use and controls had an area under the curve (AUC) ranging from 0.21 (ALT) to 0.67 (MCV). The AUC of these novel proteins showed the improvement in the detection of excessive drinkers compared to conventional laboratory tests, ranging from 0.73 (for ARID4B) to 0.86 (for ARL6).

conclusionsWe have identified 4 novel proteins that can discern subjects with excessive alcohol use. Further studies are needed to determine the clinical implications of these markers to detect excessive alcohol use and confirm abstinence.

Indexed as

ADP-Ribosylation Factor 6ADP-Ribosylation FactorsAdultAlcohol-Related DisordersAntigens, NeoplasmBiomarkersCase-Control StudiesCohort StudiesFemaleHepatocyte Growth FactorHumansMaleMiddle AgedNeoplasm ProteinsPhosphatidylcholine-Sterol O-AcyltransferasePredictive Value of TestsADP-Ribosylation Factor 6ADP-Ribosylation FactorsAntigens, NeoplasmARF6 protein, humanARID4B protein, humanARL6 protein, humanBiomarkersHepatocyte Growth Factormacrophage stimulating proteinNeoplasm ProteinsPhosphatidylcholine-Sterol O-AcyltransferaseProto-Oncogene ProteinsExcessive Alcohol UseLC/MSProteomicsSerum Markers

Identifiers

PMID25704570
PMCPMC4348329

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.